Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.39% slipped 1.10% to $164.53 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.0079% falling 2.11% to 3,640.47 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.22% falling 1.54% to 29,225.61. Johnson & Johnson closed $22.16 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock underperformed when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.64% rose 1.21% to $335.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.39% fell 0.16% to $86.64, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.32% fell 0.61% to $44.16. Trading volume (7.0 M) remained 66,527 below its 50-day average volume of 7.1 M.